By comparing the expression level of these genes on day 30 p/i, we found that in the GPC-CM and IH groups, there was a decreased Bax/Bc-2 ratio, but not in the NPC-CM group. The gene discussed is BAX; the disease is nasopharyngeal carcinoma.